Advertisement
While developing new cancer therapies, the chief scientist, Dr. DavidTsai, discovered that these peptides, once unlocked from their larger hostprotein, stimulate the production of the antioxidant enzyme Super OxideDismutase (SOD). When SOD was first discovered in 1968, it was dubbed 'theenzyme of life,' because it's the first antioxidant mobilized by the cell fordefense. Cancer sufferers, especially those undergoing chemotherapy, oftenhave high levels of free radicals, which deplete the body of antioxidants. Asa result, vital organs can be overburdened and injured due to chemotherapytreatment. With AminoAct(TM), now available through OncoNutrition(TM),chemotherapy patients have access to a functional nutritional supplement thatboosts their antioxidant levels and aids recovery from the damages ofchemotherapy.
Advertisement
Cancer Treatment Review recently published a clinical review of 19different studies indicating that antioxidant supplements taken by cancerpatients resulted in increased survival time and increased treatment response.Antioxidants mainly come from two sources, either from nutrients like VitaminC, or through antioxidant enzymes produced by the body. "AminoAct(TM)stimulates the body to produce its own antioxidants. Because our product worksfrom the inside out, users benefit from a dramatic increase in theirantioxidant levels," stated Olof Mollstedt, OncoNutrition's CEO.
"Our studies show that AminoAct(TM) increases the antioxidant levels inblood by over 200 percent in a seven-day period, while nutrient-basedantioxidants only increase levels marginally." Mr. Mollstedt continued,"Antioxidants act as a shield for healthy cells, while allowing chemotherapyto battle cancerous cells. AminoAct(TM) greatly increases the size of thatshield."
Because chemotherapy attacks not only cancer cells, but all cells,oftentimes cancer patients must stop treatment due to chemotherapy sideeffects. However, like antibiotics, chemotherapy is most effective when givenin complete cycles. "By dramatically increasing antioxidant levels,AminoAct(TM) helps patients to stay on their chemotherapy regimens, thusincreasing the overall treatment impact," stated Dr. Tsai.
In addition to stimulating SOD production, AminoAct(TM) also increases thesecretion of ghrelin, a stomach hormone that stimulates appetite. According tothe American Cancer Society, weight loss in the main cause of death for 1 in 5cancer patients. "Our research was focused on eradicating cancer by allowingchemotherapy to do the job it's intended to do," Dr. Tsai said. "Knowing thatcancer patients often succumb to death due to weight loss, when we uncoveredthat AminoAct(TM) also increases ghrelin production, we were elated."
The milk-based peptides in AminoAct(TM) are unlocked through a proprietarytechnology, and do not have adverse effects on those who are lactoseintolerant. For more information, visit www.onconutrition.com, or call 951-231-2388.To view the Multimedia News Release, go to:http://www.prnewswire.com/mnr/eqwestgroup/36121/
SOURCE OncoNutrition
